Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)
1 other identifier
observational
40
0 countries
N/A
Brief Summary
SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not yet evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2009
CompletedFirst Posted
Study publicly available on registry
January 8, 2009
CompletedStudy Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedJanuary 8, 2009
January 1, 2009
1.9 years
January 7, 2009
January 7, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
bone density
1 month
bone density
2 years
Eligibility Criteria
Healthy term newborn infants to mothers treated with SSRI and healthy controls. bone density mesurment will be applied on the 1-7 days of life.
You may qualify if:
- Term newborn infants to mothers treated with SSRI and healthy controls
You may not qualify if:
- Preterms, major congenital malformations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
January 7, 2009
First Posted
January 8, 2009
Study Start
February 1, 2009
Primary Completion
January 1, 2011
Last Updated
January 8, 2009
Record last verified: 2009-01